Related Experiment Video
Updated: Aug 2, 2025

Translational Rabbit Model of Chronic Cardiac Pacing
Published on: January 6, 2023
The VR leadless pacemaker: Results of an expert panel using the RAND/UCLA method
Juan Máximo Molina-Linde1, Ernesto Díaz-Infante2, Luis Tercedor-Sánchez3
1Health Technology Assessment Area-AETSA, Andalusian Public Foundation Progress and Health-FPS, Seville, Spain.
This study provides guidance for implanting leadless pacemakers, focusing on patient selection for the Transcatheter Pacing System single-chamber device (VR leadless). Key factors include vascular access limitations and patient health, aiming to reduce complications.
Area of Science:
- Cardiology
- Medical Devices
- Clinical Guidelines
Background:
- Leadless pacemakers aim to minimize complications from traditional transvenous pacemaker implantation.
- Current international guidelines lack specific criteria for selecting patients for leadless pacemaker implantation.
- This study addresses the need for expert consensus on indications for VR leadless pacemakers.
Purpose of the Study:
- To develop a consensus document providing medical guidance for the indication and implantation of VR leadless pacemakers.
- To offer recommendations for health professionals involved in VR leadless pacemaker procedures.
- To standardize and optimize the implantation of Transcatheter Pacing System single-chamber devices.
Main Methods:
- A panel of interventional and non-interventional cardiologists utilized the RAND/UCLA appropriateness method.
- Experts rated 64 scenarios for atrial fibrillation and 192 for sinus rhythm patients.
- Scenarios were individually and group-rated to determine appropriateness for leadless pacemaker implantation.
Main Results:
- The consensus statement summarizes recommendations based on expert opinion and literature.
- Limitation for vascular access via the superior vena cava was a critical factor in patient selection.
- Appropriateness was classified as appropriate, inappropriate, or questionable based on median ratings and agreement.
Conclusions:
- Patient selection for VR leadless pacemaker implantation is influenced by life expectancy, infection risk, prosthetic valves, LVEF, vascular access, and mobility.
- Further prospective studies are required to refine and optimize current recommendations.
- The consensus aims to improve patient outcomes by standardizing leadless pacemaker implantation criteria.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025